|
|
|
| home > white papers > Personalised Medicine - Pharma and Dx Firms Share Wider Horizons - DiagnostikNet-BB |
|
|
 WHITE PAPERS |
|
DiagnostikNet-BB
|
|
Personalised Medicine - Pharma and Dx Firms Share Wider Horizons
|
|
Personalised medicine might be a popular catch-phrase at the moment, but the term often causes confusion, as there is still no uniform definition for it. The expression can include areas as diverse as the measurement of individual risk, early detection using biomarker testing, stratification of patients suffering from a disease and predictions about its course.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Safe’n’Spray: A Winner at CPhI Festival of Pharma
Nemera’s concept device Safe'n'SprayTM was rewarded under the category 'Excellence in Pharma - Drug Delivery Devices'
More info >> |
|
 |
White Papers |
 |
|
galenIQ - The smart excipient
BENEO GmbH
galenIQ combines a multitude of outstanding characteristics and is suitable for a wide range of pharmaceutical applications. galenIQ can be used as more than just a bulk excipient. It also serves as an anti-caking agent, anti-humectant agent, stabilizer or oral care and taste agent to mention just a few additional functions.
More info >> |
|
 |
Industry Events |
 |
Clinical Operations in Oncology Trials West Coast
17-18 November 2020, Hilton San Francisco Airport Bayfront
Clinical Operations in Oncology Trials West Coast will be returning this April for another 2 day event full of thought-provoking presentations, discussions and roundtables. This years' conference highlights include the high-level, interactive immuno-oncology discussion panel where specialists from Shasta Bio Ventures, Abbvie and BeiGene shared their top tips on how to run successful and impactful immuno-oncology studies.
More info >> |
|
|
|
.jpg)
